InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Tanen David M. Officer active across 2 companies, notably Arno Therapeutics, Inc. In total, 2 reports have been published. Split: 1 buy · 0 sell. Activity tracked since 20 June 2025. The latest transaction was filed on 20 June 2025 (U). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations